PURPOSE: Mucositis occurs in almost all patients treated with radiotherapy for head and
neck cancer. The aim of this multicenter, double-blind, prospective, randomized trial was to …

Background Mucositis occurs in almost all radiotherapy‐treated head and neck cancer
patients, in approximately 75% of patients receiving hematopoietic marrow transplantation …

Purpose: To identify, classify, and evaluate agents used in the prophylaxis of oral mucositis
in irradiated head and neck cancer patients. Methods: Data sources included multiple …

BACKGROUND The objective of this study was to determine whether a nonabsorbable
antibiotic lozenge could alleviate radiation‐induced oral mucositis. METHODS Patients …

Background and purpose: To determine the frequency of mucositis and associated
outcomes in patients receiving radiotherapy (RT) for head and neck cancer through a …

Mucosal reactions in patients receiving radiation treatment for head and neck cancer are
regarded as unavoidable side‐effects. The degree of mucositis experienced is determined …

The aim of these meta-analyses was to evaluate the effectiveness of interventions for the
prevention of oral mucositis in cancer patients treated with head and neck radiotherapy …

Background. Oral mucositis is a common sequel of radiotherapy, chemotherapy, and
radiochemotherapy in patients with cancer or patients requiring hemopoietic stem cell …

Abstract Purpose/Objectives: To review the research studies on the current treatments for
radiation therapy-(RT-) induced mucositis in patients with head and neck cancer. Data …

Aim Several studies have demonstrated positive effects of benzydamine oral rinse in
prevention of radiation‐induced oral mucositis. The aim of this study was to assess the …